PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR
Soma Ghosh(Weizmann Institute of Science), Yosef Yarden(Weizmann Institute of Science), Moshit Lindzen(Weizmann Institute of Science), Saptaparna Mukherjee(Weizmann Institute of Science), Ashish Noronha(Weizmann Institute of Science), Diana Drago-García(Weizmann Institute of Science), Aakanksha Verma(Weizmann Institute of Science), Moshe Oren(Weizmann Institute of Science), Lior Kramarski(Weizmann Institute of Science), Hava Gil-Henn(Bar-Ilan University), Benjamin Geiger(Weizmann Institute of Science), Galit Eisenberg(Hadassah Medical Center), Shimon Weiss(California NanoSystems Institute), Eytan Ruppin(National Institutes of Health), Arunachalam Sekar(Weizmann Institute of Science), Sushant Patkar(National Institutes of Health), Joseph Green(Weizmann Institute of Science), Michal Lotem(Hadassah Medical Center), Nishanth Belugali Nataraj(Weizmann Institute of Science), Arkaprabha Basu(California NanoSystems Institute), Sabina Winograd‐Katz(Weizmann Institute of Science), Yan Lender(Ben-Gurion University of the Negev)
Cited by 44
Related Papers
Semiconductor Nanocrystals as Fluorescent Biological Labels
|Science|1998|8.6k
Decision making by p53: life, death and cancer
|Cell Death and Differentiation|2003|1.1k
c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
|Genes & Development|1998|861
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
|Nature Medicine|2018|813
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
|Genes & Development|2001|702